Str/581 Week 3 Discussion Question Answers

Discussion QuestionsQuestion 1Acorda Therapeutics is a biotechnological company that since 1995 has been dedicated to developing drug therapies that help those with nervous system disorders improve their neurological functions. Specifically, the company offers neurology therapies to those who might be suffering from Parkinson’s disorder, multiple sclerosis, migraine and other medically recognized neurological diseases. Acorda fulfills their clients need by offering two FDA approved drugs; Ampyra and Inbrija (levodopa inhalation powders) (Acorda, 2019). The former is administered through ARCUS technology with the company owning the rights to use it in exclusion of other competitors. The company thus has a strong competitive advantage when compared to its close competitors.The key factors that help the company have competitive advantage can be understood using the three circles analysis. For starters, the company understands that its customers have neurological disorders that require more than delivering drugs. Most of its clients are people who value a working drug that helps them alleviate the problems associated with their medical conditions. In that regard, the company has a competitive advantage because it has the rights to produce drugs such as Ampyra and Inbrija which are needed by the clients (Fahy, 2002). Despite the fact that other companies